Rolando Marquez


Practice Areas:
Contact Information:
Phone: 646-733-5765

B.S., Brown University, 1994, M.S., New York University, 1998
J.D., Fordham University School of Law, 2003

Bar Admissions:
New York, 2005
Rolando G. Marquez represents whistleblowers in a wide variety of qui tam lawsuits brought under the federal False Claims Act and parallel state false claims laws. His practice includes pursuing fraud cases involving the healthcare industry, defense contractors, and government procurement.

Mr. Marquez’s representative False Claims Act matters include United States ex rel. Miller v. CareCore National LLC, et al. (resulting in a $54 million recovery for the United States as well as 28 States and the District of Columbia in an intervened action arising from the improper prior authorization of costly diagnostic tests which caused federal and state healthcare programs to pay for tests that were not properly authorized as being medically reasonable or necessary); Mason v. Medline (resulting in a recovery of $85 million for the United States in a non-intervened case arising from unlawful kickbacks, bribes, and other illegal remuneration to induce health care providers to continue to purchase defendant’s medical supplies, including supplies paid for with government funds tainted by the kickbacks); and United States ex rel. Marchese v. Cell Therapeutics, Inc. (resulting in a $10.5 million recovery for the United States in an intervened action arising from the unlawful off-label promotion of the cancer drug Trisenox).

From December 2012 to March 2014, Mr. Marquez was a Senior Litigation Counsel in a boutique New York class-action firm as a member of its False Claims Act practice group. Mr. Marquez was part of the co-counsel team that litigated one of the largest qui tam lawsuits ever to settle on a non-intervened basis against Omnicare, Inc., the nation's largest provider of pharmacy services to nursing home patients, and which returned $120 million to the United States Treasury to resolve kickback and false-claims allegations. In addition, Mr. Marquez represented a whistleblower in an action against Smith & Nephew, one of the world’s largest medical device manufacturers, in which the company sold products to the government that were manufactured in countries not designated as trade partners of the United States in violation of the Trade Agreements Act.

Before he started in the False Claims Act arena, Mr. Marquez was part of the Milberg team that served as co-lead plaintiffs’ counsel in In re Tyco International, Ltd. Securities Litigation, one of the largest securities fraud and accountant liability class action suits ever to settle, recovering over $3.2 billion for the company’s injured shareholders.

Prior to joining Milberg initially, Mr. Marquez was an associate at a boutique New York patent firm, where he concentrated on patent litigation matters involving medical device, computer software, and consumer electronic device technologies.

Mr. Marquez received a B.S. degree from Brown University in 1994 and his M.S. degree from New York University in 1998. In 2003 he received his J.D. degree from Fordham University School of Law.

Mr. Marquez is admitted to practice in the state courts of New York as well as in the United States District Courts for the Southern and Eastern Districts of New York and the United States Patent and Trademark Office.